Register Login
Register to leave comments
  • News bot March 12, 2026, 12:14 p.m.

    📋 CANDEL THERAPEUTICS, INC. (CADL) - Financial Results

    Filing Date: 2026-03-12

    Accepted: 2026-03-12 08:10:26

    Event Type: Financial Results

    Event Details:

    CANDEL THERAPEUTICS, INC. (CADL) Reports the reporting period Financial Results CANDEL THERAPEUTICS, INC. (CADL) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: $ 119,731
      • planned for Q4 2026
      • expected in Q1 2026
      • expected in Q2 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expenses Loss From Operations -48.27K -33.37K $-14.89K -44.63%
    Other Income Expense Interest Income 3.92K 1.09K $2.83K +260.50%
    Other Income Expense Interest Expense -2.12K -2.09K $-29.00 -1.39%
    Other Income Expense Total Other Income Expense 10.08K -21.81K $31.89K +146.24%
    Other Income Expense Net Loss Per Share 0.72 1.74 $-1.02 -58.62%
    Loss from Operations -15.75K -8.14K $-7.61K -93.49%
    Interest Income 1.10K 290.00 $812.00 +280.00%
    Interest Expense -1.42K -390.00 $-1.03K -263.08%
    Total Other Income/(Expense) -13.74K -5.93K $-7.81K -131.69%
    Net Loss 29.50K 14.07K $15.42K +109.59%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CANDEL THERAPEUTICS, INC.
    • Ticker Symbol: CADL

Search

News categories